(Q80551920)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603762%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603762%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603762%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Laura Airas

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603762%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

H Irjala

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603762%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

30 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603762%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

published in

Neurological Sciences

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603762%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603762%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603762%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

121-126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603762%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10072-007-0803-3

1 January 2020

exact match

0 references

cites work

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

1 reference

12 December 2020

Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire

1 reference

12 December 2020

The regulatory role of natural killer cells in multiple sclerosis

1 reference

12 December 2020

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

1 reference

12 December 2020

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

12 December 2020

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells

1 reference

12 December 2020

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

1 reference

12 December 2020

Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity

1 reference

12 December 2020

NK cell-mediated lysis of autologous human oligodendrocytes

1 reference

12 December 2020

IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells

1 reference

12 December 2020

Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.

1 reference

12 December 2020

Natural killer type 2 bias in remission of multiple sclerosis

1 reference

12 December 2020

Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis

1 reference

12 December 2020

Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients.

1 reference

12 December 2020

Fine analysis of cytolytic and natural killer T lymphocytes in the CSF in multiple sclerosis and other neurologic diseases

1 reference

12 December 2020

A role for natural killer cells in the immunopathogenesis of multiple sclerosis.

1 reference

12 December 2020

Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis

1 reference

12 December 2020

Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Effect of IFNbeta and anti-IFNbeta antibodies on NK cells in multiple sclerosis patients

1 reference

12 December 2020

The natural killer cell -- friend or foe in autoimmune disease?

1 reference

12 December 2020

The biology of NKT cells

1 reference

12 December 2020

The biology of human natural killer-cell subsets

1 reference

12 December 2020

Further lymphocyte characterization in the central nervous system in multiple sclerosis

1 reference

12 December 2020

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

12 December 2020

A subset of natural killer cells is greatly expanded within inflamed joints

1 reference

12 December 2020

The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.

1 reference

12 December 2020

10.1007/S10072-007-0803-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17603762%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference